The indication for orthotopic heart transplantation (HTx) is limited to those who fulfill the indication criteria and those who are anticipated to recover quality of life by HTx. Thus, those who suffer from cancer or other systemic diseases that progress and involve multiple organs are not considered to be HTx candidates. However, not all patients with neuromuscular dystrophy are considered to be HTx candidates; there is a group of patients who could be considered to be HTx candidates under certain conditions. In this review, I will explain the indications for HTx for the pediatric population in Japan and discuss the conditional indications for those who have systemic diseases.
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